[Treatment of hyperuricemia during cytostatic therapy].
The increase in serum uric acid induced by cytostatic drugs may be treated by a combined low-dose uricostatic and uricosuric regimen. The results obtained in an intraindividual cross-over study demonstrate the significant influence on serum uric acid and its renal excretion.
D000230:Adenocarcinoma / Q000097:blood / Q000188:drug therapy; D000328:Adult; D000368:Aged; D000493:Allopurinol / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000097:blood / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006801:Humans; D008223:Lymphoma / Q000097:blood / Q000188:drug therapy*; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood / Q000188:drug therapy; D012509:Sarcoma / Q000097:blood / Q000188:drug therapy; D014527:Uric Acid / Q000097:blood* / Q000652:urine
D000970:Antineoplastic Agents; D014527:Uric Acid; D000493:Allopurinol
Hyperurikämie-Behandlung bei zytostatischer Therapie.